Mutational profiles in HIV-1 protease correlated with phenotypic drug resistance
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 13, 2011
Grant Date -
Mar 5, 2009
app pub date -
Oct 30, 2008
filing date -
Jul 1, 2002
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
The present invention is directed to the field of nucleic acid diagnostics and the identification of base variation in target nucleic acid sequences. More particularly, the present invention relates to the use of such genotypic characterization of a target population of HIV and the subsequent association, i.e., correlation, of this information to phenotypic interpretation in order to correlate virus mutational profiles with drug resistance. The invention also relates to methods of utilizing the mutational profiles of the invention in drug development, i.e., drug discovery, drug design, drug modification, and therapy, treatment design, clinical management and diagnostic analysis.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully